Cargando…
MicroRNAs as a therapeutic target for cardiovascular diseases
MicroRNAs (miRNAs) are tiny, endogenous, conserved, non-coding RNAs that negatively modulate gene expression by either promoting the degradation of mRNA or down-regulating the protein production by translational repression. They maintain optimal dose of cellular proteins and thus play a crucial role...
Autores principales: | Mishra, Paras Kumar, Tyagi, Neetu, Kumar, Munish, Tyagi, Suresh C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822884/ https://www.ncbi.nlm.nih.gov/pubmed/19320780 http://dx.doi.org/10.1111/j.1582-4934.2009.00744.x |
Ejemplares similares
-
MicroRNAs as therapeutic targets in cardiovascular disease
por: Laggerbauer, Bernhard, et al.
Publicado: (2022) -
MicroRNAs in Huntington’s Disease: Diagnostic Biomarkers or Therapeutic Agents?
por: Dong, Xiaoyu, et al.
Publicado: (2021) -
MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets
por: Hussen, Bashdar Mahmud, et al.
Publicado: (2021) -
Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target
por: Leng, Qianru, et al.
Publicado: (2022) -
MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics
por: Varshney, Jyotika, et al.
Publicado: (2015)